Caitong International Asset Management Co., Ltd
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1963355
HONG KONG, K3
Position in SUPN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$45,254
+$32,710 QoQ
Shares Held
973
+144.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#247
of 330 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caitong International Asset Management Co., Ltd holds $770,442 across 41 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
20,925 | $209,250 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
11,751 | $170,271 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
6,656 | $106,695 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,099 | $71,114 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
973 | $45,254 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
842 | $30,480 | |
| 7 | LQDA |
Liquidia Corp
|
331 | $26,390 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,746 | $21,748 |
All Filings in SUPN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,254 | 973 | Shares | Sole | 2026-08-05 | |
| 2025-06-30 | $12,544 | 398 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $41,265 | 1,260 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||